Home »
Cancer is the second leading cause of death globally, accounting for nearly 10 million deaths each year. Late-stage diagnosis is a major contributor of cancer-related mortality, as...
Immunotherapy has revolutionized cancer treatment over the past decade, providing potentially lifesaving therapies to many patients who otherwise would have limited options. Despite its success...
This year at the AACR Annual Meeting, the premier cancer meeting in the world, data from clinical trials testing the latest cancer treatments were featured in three...
As we spring into a new month, it is once again time for our monthly staple of Editors’ Picks. For...
For Bruce Hill, who was diagnosed with stage 4 clear cell renal cell carcinoma (RCC) in 2017, scientific progress...
The word myeloma stems from the Greek word “myelos,” for marrow. Indeed, this type of blood cancer begins in the plasma cells, a type...
With the August 2020 U.S. Food and Drug Administration approvals of the Guardant 360 CDx and FoundationOne Liquid CDx...
Numerous studies have shown that individuals with cancer fare worse than the general population if they contract COVID-19, with...
Back for the month of February is our regular staple, Editors’ Picks, which features the “must read” articles that...
As infections from SARS-CoV-2 began to rapidly spread across the United States in early 2020, many nonessential medical procedures, including cancer screenings, were...